Ivan Tkáč
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
Papers in
-
- Diabetes Treatment and Management 16
- Diabetes, Cardiovascular Risks, and Lipoproteins 8
- Pharmacology 15
- Pharmacogenetics and Drug Metabolism 15
- Co-authors
- Martin Javorský (27 shared papers)Lucia Klimčáková (15 shared papers)Ružena Tkáčová (16 shared papers)Zbyněk Schroner (10 shared papers)Itamar Raz (1 shared paper)Miriam Kozárová (15 shared papers)Jozef Židzik (17 shared papers)Vera Bril (1 shared paper)
In The Last Decade
Ivan Tkáč
76 papers receiving 2k citations
Ivan Tkáč's Hit Papers
Peers
Comparison fields: 5 of 87
- Pharmacology 471
- Nephrology 408
- Endocrinology, Diabetes and Metabolism 472
- Genetics 297
- Physiology 165
Countries citing papers authored by Ivan Tkáč
This map shows the geographic impact of Ivan Tkáč's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ivan Tkáč with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ivan Tkáč more than expected).
Fields of papers citing papers by Ivan Tkáč
This network shows the impact of papers produced by Ivan Tkáč. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ivan Tkáč. The network helps show where Ivan Tkáč may publish in the future.
Co-authors
The 25 scholars most cited alongside Ivan Tkáč, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 79 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2019 | 527 |
| 2 | 2016 | 173 | |
| 3 | 2012 | 100 | |
| 4 | 2016 | 91 | |
| 5 | 2016 | 83 | |
| 6 | 2011 | 76 | |
| 7 | 1997 | 73 | |
| 8 | 2010 | 63 | |
| 9 | 1998 | 54 | |
| 10 | 2016 | 44 | |
| 11 | 2009 | 41 | |
| 12 | 2005 | 39 | |
| 13 | 2013 | 35 | |
| 14 | Cardiovascular risk and insulin resistance in patients with obstructive sleep apnea. | 2008 | 30 |
| 15 | 2011 | 26 | |
| 16 | 2016 | 26 | |
| 17 | 2021 | 26 | |
| 18 | 2006 | 25 | |
| 19 | 2010 | 25 | |
| 20 | 2013 | 25 |
About Ivan Tkáč
Ivan Tkáč is a scholar working on Endocrinology, Diabetes and Metabolism, Pharmacology, Genetics, Cardiology and Cardiovascular Medicine and Pulmonary and Respiratory Medicine, having authored 79 papers that have together received 2k indexed citations. Recurring topics across this work include Genetic Associations and Epidemiology (17 papers), Diabetes Treatment and Management (16 papers), Pharmacogenetics and Drug Metabolism (15 papers), Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Chronic Kidney Disease and Diabetes (5 papers), Peripheral Artery Disease Management (5 papers), Aortic aneurysm repair treatments (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). The work is most often cited by research in Pharmacology (471 citations), Nephrology (408 citations), Endocrinology, Diabetes and Metabolism (472 citations), Genetics (297 citations) and Physiology (165 citations). Ivan Tkáč has collaborated with scholars based in Slovakia, Czechia and Canada. Frequent co-authors include Martin Javorský, Lucia Klimčáková, Ružena Tkáčová, Zbyněk Schroner, Itamar Raz, Miriam Kozárová, Jozef Židzik, Vera Bril, Jan Salagovic and Angela Molčányiová. Their work appears in journals such as Physiological Research, Diabetes Research and Clinical Practice, Diabetes Care, Diabetes Obesity and Metabolism and Pharmacogenomics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.